During the past decade, Piedmont Fayette Hospital conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 31 clinical trials were completed, i.e. on average, 182.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 13 clinical trials were completed. i.e. 216.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Piedmont Fayette Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 22 trials, followed by "SWOG Cancer Research Network" with 12 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "NRG Oncology" with 6 trials sponsored and "Radiation Therapy Oncology Group" with 6 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Piedmont Fayette Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 32 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Piedmont Fayette Hospital" are "Invasive Breast Carcinoma" (5 trials), "Breast Cancer" (4 trials), "Lymphoma" (4 trials), "Prostate Cancer" (4 trials) and "Colorectal Cancer" (3 trials). Many other conditions were trialed in "Piedmont Fayette Hospital" in a lesser frequency.

Most popular intervention types in "Piedmont Fayette Hospital" are "Drug" (41 trials), "Other" (36 trials), "Biological" (23 trials), "Radiation" (16 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (18 trials), "Quality-of-Life Assessment" (11 trials), "Paclitaxel" (10 trials), "Bevacizumab" (8 trials) and "Carboplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Piedmont Fayette Hospital" are 39 trials for "All" genders, 12 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Piedmont Fayette Hospital". undefined are not yet recruiting, 6 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Piedmont Fayette Hospital, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Piedmont Fayette Hospital, 0 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".